CSRXP: LAWMAKERS MUST HOLD BIG PHARMA ACCOUNTABLE FOR UNCONSCIONABLE PRICE HIKES ON COVID-19 VACCINES AND TREATMENTS

Senate HELP Committee Hearing with Moderna CEO Offers Prime Opportunity to Push Back on Brand Name Drug Company Profiteering Ahead of Shift to Commercial Distribution For Immediate Release Contact:

03-22-2023 Read More

DOSE OF REALITY: LAWMAKERS GET CHANCE TO HOLD BIG PHARMA ACCOUNTABLE FOR COVID-19 PRICE-GOUGING AHEAD OF COMMERCIAL DISTRIBUTION

Senate HELP Committee to Question Moderna CEO on Nearly 500 Percent Price Hike on COVID-19 Vaccine Developed with Taxpayer Investment As COVID-19 vaccine and therapeutic coverage shifts to the

03-20-2023 Read More

BIRDS OF A FEATHER: PFIZER AND SANOFI ACQUIRE FELLOW PRICE-GOUGERS IN LATEST BIG PHARMA M&A DEALS

Big Pharma Giants With Affinity for Price Hikes Acquire Smaller Brand Name Drug Companies with Their Own History of Egregious Pricing Practices This week, two Big Pharma giants, both

03-17-2023 Read More

BIG PHARMA WATCH: NEW REPORT HIGHLIGHTS BIG PHARMA’S RAPIDLY RISING LAUNCH PRICES

Wall Street Journal Analysis Finds Median Monthly Price for Newly Approved Drugs Nearly Tripled in 10 Years, from $2,624 in 2011 to $7,034 in 2022 A new analysis released this week by The Wall

03-10-2023 Read More

THEY SAID IT! LAWMAKERS, DRUG PRICING ADVOCATES AND ECONOMIC EXPERTS CALL FOR SOLUTIONS TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE

Event Highlights Importance of Holding Big Pharma Accountable to Boost Competition and Lower Drug Prices In case you missed it, on Thursday, The Hill hosted a virtual event

03-10-2023 Read More

CSRXP STATEMENT ON ELI LILLY ANNOUNCEMENT ON PRICE OF INSULIN PRODUCTS

More Big Pharma Companies Should Also Lower Their Insulin Prices, But Policymakers Must Address Root Cause of High Drug Prices To Secure Lasting Relief For Immediate ReleaseContact: Jon

03-1-2023 Read More

BIG PHARMA WATCH: NYT REPORT DOCUMENTS NARCOLEPSY DRUG MAKER’S EGREGIOUS EXPLOITATION OF PATENT SYSTEM

Anti-Competitive Strategy Around Brand Name Narcolepsy Medications Blocked Patients from Accessing Alternatives In case you missed it, on Tuesday, The New York Times reported on anti-competitive

02-28-2023 Read More

BIG PHARMA EARNINGS WATCH: ABBVIE AND ASTRAZENECA

Big Pharma Giants Once Again Top Wall Street Expectations in Final Round of Fourth Quarter Earnings Reports While Continuing to Price-Gouge American Patients A final round of Big Pharma 2022

02-28-2023 Read More

BIG PHARMA EARNINGS WATCH: MERCK, SANOFI, BRISTOL-MYERS SQUIBB AND ELI LILLY

Four Big Pharma Giants That Hiked Drug Prices on American Patients in 2022 and First Weeks of 2023 All Beat Wall Street Earnings Expectations Another round of fourth-quarter earnings reports from

02-21-2023 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.